Statistics for Armata Pharmaceuticals (id:219 ARMP)
Valuation metrics
Market cap
81.05M
Enterprise value
216.71M
Trailing P/E (ttm)
-1.10
Forward P/E
-1.43
PEG ratio
-1.43
Price/Sales (ttm)
21.79
Price/Book (mrq)
-1.49
Enterprise Value/Revenue
58.27
Enterprise Value/EBITDA
-5.30
Overview
Shares outstanding
36.18M
Float
11.04M
Shares short
4.54K
% Held by insiders
0.70%
% Held by institutions
0.04%
Average volume (10 days)
12.66K
Average volume (90 days)
Price summary
52-Week low
1.98
52-Week high
4.48
52-Week change
3.33%
Beta
0.80
50-Day moving average
2.34
200-Day moving average
2.82
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
May 10th, 2019
Ex-dividend date
Last split factor
2:1
Last split date
May 10th, 2019
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
-1,130.87%
Operational effectiveness
Return on assets
-25.09%
Return on equity
215.33%
Income statement
Revenue (ttm)
0.10
Revenue per share (ttm)
0.10
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-40,911,000.00
Net income to common (ttm)
-67,043,000.00
Diluted EPS (ttm)
-1.86
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
26.40M
Total cash per share (mrq)
0.73
Total debt (mrq)
146.14M
Total Debt/Equity (mrq)
-2.87
Current ratio (mrq)
25.10%
Book value per share (mrq)
-0.89
Cash flow
Cash flow statement
-38,554,000.00
Levered free cash flow (LFCF)
-31,061,124.00